Literature DB >> 10971702

Intercalated duct hyperplasia: possible relationship to epithelial-myoepithelial carcinoma and hybrid tumours of salivary gland.

R Chetty1.   

Abstract

AIMS: The aims of this study were to ascertain the incidence of intercalated duct hyperplasia in association with cases of epithelial-myoepithelial carcinoma (EMC), and to explore a possible relationship between them and hybrid carcinomas of salivary glands. METHODS AND
RESULTS: Seven cases of EMC with sufficient surrounding non-tumour parotid were examined. Three cases contained foci of intercalated duct hyperplasia adjacent to the tumour. One of the cases was a hybrid tumour composed of EMC and mucoepidermoid carcinoma. The hyperplastic intercalated ducts formed multiple foci within the salivary parenchyma and were composed of bland, uniform ducts. Cytological atypia was not identified.
CONCLUSIONS: Intercalated duct hyperplasia may be a precursor lesion to EMC. Furthermore, it may also explain why EMC is frequently associated with other salivary gland carcinomas, so-called hybrid tumours, as well as sharing histological features with adenoid cystic carcinoma. Recognition of the latter is of particular importance because adenoid cystic carcinoma carries a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971702     DOI: 10.1046/j.1365-2559.2000.00976.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

1.  Hybrid Intercalated Duct Lesion of the Parotid: Diagnostic Challenges of a Recently Described Entity with Fine Needle Aspiration Findings.

Authors:  Yingting Mok; Yin Huei Pang; Ming Teh; Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2015-10-17

2.  Intercalated duct lesion of the parotid.

Authors:  Matthew R Naunheim; Harrison W Lin; William C Faquin; Derrick T Lin
Journal:  Head Neck Pathol       Date:  2012-01-22

3.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.

Authors:  Raja R Seethala; Göran Stenman
Journal:  Head Neck Pathol       Date:  2017-02-28

4.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.

Authors:  Alena Skálová; Martin D Hyrcza; Ilmo Leivo
Journal:  Head Neck Pathol       Date:  2022-03-21

5.  Salivary gland hybrid tumour revisited: could they represent high-grade transformation in a low-grade neoplasm?

Authors:  Henrik Hellquist; Alena Skalova; Bahram Azadeh
Journal:  Virchows Arch       Date:  2016-09-07       Impact factor: 4.064

Review 6.  Hybrid tumours of the salivary glands. A report of two cases involving the palate and a review of the literature.

Authors:  Luz María Ruíz-Godoy; Adalberto Mosqueda-Taylor; Lourdes Suárez-Roa; Adela Poitevin; Esther Bandala-Sánchez; Abelardo Meneses-García
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-02-12       Impact factor: 2.503

7.  Adenomatous ductal proliferation/hyperplasia in the parotid gland associated without any other pathological lesions; a report and survey of the literatures.

Authors:  Bhoj Raj Adhikari; Michiko Nishimura; Kosuke Takimoto; Fumiya Harada; Aya Onishi; Daichi Hiraki; Durga Paudel; Puja Neopane; Masafumi Utsunomiya; Tetsuro Morikawa; Koki Yoshida; Jun Sato; Mamata Shakya; Eiji Nakayama; Hiroki Nagayasu; Yoshihiro Abiko
Journal:  Med Mol Morphol       Date:  2018-05-15       Impact factor: 2.309

8.  A hybrid carcinoma of epithelial-myoepithelial carcinoma and adenoid cystic carcinoma in maxillary sinus.

Authors:  Jeong-Su Woo; Soon-Young Kwon; Kwang-Yoon Jung; Insun Kim
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

9.  Clear cell predominant epithelial-myoepithelial carcinoma of the hard palate - role of immunohistochemistry.

Authors:  Radha R Pai; Kausalya Sahu; Anand U Kini
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2008-03-19

10.  Salivary gland tumors in Uganda: clinical pathological study.

Authors:  Edda A M Vuhahula
Journal:  Afr Health Sci       Date:  2004-04       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.